The RSB Show 12-4-20 – Cordie Lee Williams, Dr. Frank King, James Lyons-Weiler https://t.co/rEHPiu00Jq
— Robert Scott Bell (@rsbellmedia) December 4, 2020
December 4th, 2020 3-5PM ET
Friday on The Robert Scott Bell Show:
Special Guest: Cordie Lee Williams
Dr. Cordie Williams is a US Marine, a professional speaker, and a leader in the chiropractic profession.
In the spring of 2020, Dr. Cordie felt his Constitutional Rights, and the rights of so many other Americans, were being violated by the state of California. So, he did what any veteran, father, and business owner would do – he took action. Dr. Cordie picked up a megaphone and began speaking up at protests all across California.
His common-sense message was well received at the protests. In fact, his speech from May 1, 2020 at the state capitol in Sacramento, CA has received more than 8 million hits on Facebook and counting, and has generated over 15 million views across all platforms.
Emboldened by government overreach from the state of California, Dr. Cordie was inspired to found 1776 Forever Free to help protect the freedom of all Americans.
The Healing Revolution with Dr. Frank King!
Dr. Frank King joins RSB to keep the Healing Revolution going! How do you over come adversity? How do you overcome pain? Get ready for some not-so-painful truth about how homeopathy can help you safely get over pain by addressing the root cause. This is vitally important because much of the allopathic world has adopted the use of highly toxic, addictive and even deadly painkilling drugs. There are safe ways to deal with both acute pain and chronic pain. We’ll discuss some important formulas that should be in your remedy kit to keep you going when pain would normally slow you down or stop you altogether.
The King Bio Journey
In my early 20s, my aging father put me in charge of the farm. My passion for all things natural was growing by leaps and bounds, so I converted our operations to an organic, biodynamic farm.
Meanwhile, my enthusiasm for the healing arts grew. I read everything I could about natural foods and health. I went to hear a crazy eighty-year-old man named Dr. Paul Bragg speak, and he exploded my old-age stereotypes! A few years later, I was astounded to hear that he reportedly died from complications received from a surfing accident. In his 80s!
These were my days of discovery, as I learned how detrimental many aspects of the Industrial Revolution and the so-called advances of modern science and technology have been to human health. I began to see a need for another kind of revolution.
I still remember the day in 1975 when I decided to become a healer instead of a farmer. I soon obtained two degrees: Doctor of Chiropractic and Naturopathic Doctor. In 1979, I established a multi-practitioner natural health clinic.
People drove from miles around to visit our clinic that was located in the spacious house my father had built on our farm. We gained a reputation for catching people who were at the end of their ropes, whose challenging symptoms left other doctors scratching their heads.
“Specializing in Difficult Cases” became the tag line on our business cards. We were passionate about finding the root causes of illness, rather than simply treating symptoms. We also helped pet owners by giving chiropractic adjustments and natural remedies to dogs, cats, horses, buffalos and even chickens.
Meanwhile, I developed new approaches to natural health care, including pure water-based homeopathic medicines. In 1989, I established King Bio, an FDA-registered company that researches, manufactures and sells natural homeopathic products. King Bio soon expanded into six brands: Dr. King’s Natural Medicine, Natural Pet Pharmaceuticals, Natural Veterinary Pharmaceuticals, SafeCareRx, Safecare and Aquaflora products.
Special Guest James Lyons-Weiler
James “Jack” Lyons-Weiler, PhD is a Pittsburgh-area scientist, lecturer, and author, who has worked collaboratively for over twenty years on over one hundred research studies. After conducting research in Amazonia on prehistorical shifts in climate change, he focused on questions of how to best understand evolutionary biology, and to questions on the origins of biological diversity. Thanks to a Sloan Foundation fellowship, he was then able to shift focus to biomedical problems in cancer, diabetes, heart disease, infectious disease and many other aspects of clinical, biomedical and translational research. To provide a lasting monument to his mother, and to help others share advances in cancer research, he served as the Founding Editor-in-Chief of the open access, peer-reviewed research journal Cancer Informatics (Libertas Academica). An expert in study design, complex data analysis, genetics and systems biology, he has written three books: “Ebola: An Evolving Story” (2015), “Cures vs. Profits: Successes in Translational Research” (2016), and “The Environmental and Genetic Causes of Autism” (2016). For “Causes”, he reviewed over 3,000 research studies, and he cited >2,000 in the final product. He is currently CEO/Director of The Institute for Pure and Applied Knowledge, which conducts research without profit motive to “Reduce Human Pain and Suffering Through Knowledge.” A regular featured guest on many radio shows focused on public health, Dr. Lyons-Weiler has reached millions with his defense of science as a way of knowing. He sees the public’s current widespread distrust in science as misplaced, because individual scientists and corporations should be held accountable when they mislead the public for profit motives, not the entire enterprise of science.
Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination We performed a retrospective analysis spanning ten years of pediatric practice focused on patients with variable vaccination born into a practice, presenting a unique opportunity to study the effects of variable vaccination on outcomes. The average total incidence of billed office visits per outcome related to the outcomes were compared across groups (Relative Incidence of Office Visit (RIOV)). RIOV is shown to be more powerful than odds ratio of diagnoses. Full cohort, cumulative incidence analyses, matched for days of care, and matched for family history analyses were conducted across quantiles of vaccine uptake. Increased office visits related to many diagnoses were robust to days-of-care-matched analyses, family history, gender block, age block, and false discovery risk. Many outcomes had high RIOV odds ratios after matching for days-of-care (e.g., anemia (6.334), asthma (3.496), allergic rhinitis (6.479), and sinusitis (3.529), all significant under the Z-test). Developmental disorders were determined to be difficult to study due to extremely low prevalence in the practice, potentially attributable to high rates of vaccine cessation upon adverse events and family history of autoimmunity. Remarkably, zero of the 561 unvaccinated patients in the study had attention deficit hyperactivity disorder (ADHD) compared to 0.063% of the (partially and fully) vaccinated. The implications of these results for the net public health effects of whole-population vaccination and with respect for informed consent on human health are compelling. Our results give agency to calls for research conducted by individuals who are independent of any funding sources related to the vaccine industry. While the low rates of developmental disorders prevented sufficiently powered hypothesis testing, it is notable that the overall rate of autism spectrum disorder (0.84%) in the cohort is half that of the US national rate (1.69%). The practice-wide rate of ADHD was roughly half of the national rate. The data indicate that unvaccinated children in the practice are not unhealthier than the vaccinated and indeed the overall results may indicate that the unvaccinated pediatric patients in this practice are healthier overall than the vaccinated. View Full-Text
SARS-CoV-2 Transmission among Marine Recruits during Quarantine A total of 1848 recruits volunteered to participate in the study; within 2 days after arrival on campus, 16 (0.9%) tested positive for SARS-CoV-2, 15 of whom were asymptomatic. An additional 35 participants (1.9%) tested positive on day 7 or on day 14. Five of the 51 participants (9.8%) who tested positive at any time had symptoms in the week before a positive qPCR test. Of the recruits who declined to participate in the study, 26 (1.7%) of the 1554 recruits with available qPCR results tested positive on day 14. No SARS-CoV-2 infections were identified through clinical qPCR testing performed as a result of daily symptom monitoring. Analysis of 36 SARS-CoV-2 genomes obtained from 32 participants revealed six transmission clusters among 18 participants. Epidemiologic analysis supported multiple local transmission events, including transmission between roommates and among recruits within the same platoon. Among Marine Corps recruits, approximately 2% who had previously had negative results for SARS-CoV-2 at the beginning of supervised quarantine, and less than 2% of recruits with unknown previous status, tested positive by day 14. Most recruits who tested positive were asymptomatic, and no infections were detected through daily symptom monitoring. Transmission clusters occurred within platoons. (Funded by the Defense Health Agency and others.).
In this study, a huge % of PCR-positive Marine recruits gave samples from COVID19 viral genome sequence could not be determined. The authors somehow missed that their study demonstrates unacceptably high false positive rates.
Ten Fatal Errors: Scientists Attack Paper That Established Global PCR Driven Lockdown War has broken out in the scientific literature that strikes at the existential core of Covid-19 and its proposed causative virus. At the heart of the controversy lies the fact that the creators of the most commonly used test, the RT-PCR, published instructions for how to test for SARS-CoV-2 “without having virus material available,” in their own words, relying instead on the Chinese scientists’ genetic sequence published on the internet. The paper “Detection of 2019 novel coronavirus (2019-nCoV) by real-time PCR” was published 24 hours after it was submitted to Eurosurveillance, clearly evading peer review. Its lead authors were Christian Drosten and Victor Corman, which is how it took on the title “Corman-Drosten paper.” It provided the “recipe,” or work flow for the Covid-19 diagnostic test, quickly applied all over the world, after it was accepted as the standard of testing by the WHO. German scientist Christian Drosten was also a co-discoverer of the SARS-associated coronavirus, and developed a test for it in 2003. Drosten, who heads the Charite Institute of Virology in Berlin, and a team of fellow scientists in Europe and Hong Kong, moved very quickly, as soon as cases of the illness were being reported out of Wuhan in December of 2019. They submitted the paper on Jan. 21, it was published in Eurosurveillance on Jan. 23,* and was immediately accepted as the standard of testing internationally, by the WHO, which began sending test kits to affected regions. (Fact check: was it 24 hours? Corbett says yes.)
What’s driving coronavirus vaccine hesitancy in US? The United States is potentially days away from approving the first round of coronavirus vaccines just nine months after the global pandemic ripped through every state, claimed hundreds of thousands of lives and crippled the once robust economy. And yet, millions have vowed not to take the fast-developed two-shot vaccines despite 95% efficacy rates from pharmaceutical companies Pfizer and BioNTech and another from Moderna. Why the hesitancy and how long could the COVID-19 crisis continue as a result? “People are wary of misinformation and don’t really know who to trust anymore. The development of the vaccines at this rapid pace is unprecedented, and there is a significant amount of fear and confusion,” Dr. Attila Hertelendy, a Florida-based expert in biomedicine and emergency and disaster management, told Fox News. “Many are of the mindset, ‘Let’s see if there are any side effects or anyone dies.'” In addition to Pfizer and Moderna’s candidates, dozens of other vaccines are under trial right now, with scientists saying many others are showing promise. One trial was halted last month after a candidate suffered an “adverse reaction” but it has since resumed. “Many medical products come with potential side effects or risks,” noted Julie Swann, a professor and department head of industrial and systems engineering at North Carolina State University, who served as a science adviser for the H1N1 pandemic response at the Centers for Disease Control and Prevention (CDC) in 2009. “We are balancing those against the risk of not taking the vaccine, knowing that SARS-CoV-2 has a high infectivity rate and a risk of severe outcomes.”